α-2a interferon therapy and antibody for
✍
E. Törnebohm-Roche; M. Merup; D. Lockner; Dr. C. Paul
📂
Article
📅
1995
🏛
John Wiley and Sons
🌐
English
⚖ 479 KB
👁 1 views
In ten patients with essential thrombocythemia and polycythemia Vera with thrombocytosis we have investigated the therapeutic effect of recombinant a-2a interferon (Roceron-A@) given subcutaneously in a maintenance dosage of 3 million units three times weekly. The aim was to normalize the platelet